Actionnariat et activité des initiés pour Serina Therapeutics, Inc. (SER): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.16 |
| Capitalisation | $32M |
| Bourse | AMEX |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-22 | Simon Farrell | A-Award | 30,500 | $66K |
| 2026-07-22 | Simon Farrell | |||
| 2026-07-07 | Brannan Stephen K. | P-Purchase | 1,000 | $2K |
| 2026-06-17 | Venkatesan Jay | C-Conversion | 224,152 | $504K |
| 2026-06-17 | Venkatesan Jay | A-Award | 15,250 | $30K |
| 2026-05-22 | Venkatesan Jay | P-Purchase | 589 | $1K |
| 2026-06-17 | Venkatesan Jay | C-Conversion | 96,525 | $500K |
| 2026-06-17 | Bailey Gregory | C-Conversion | 6,666,667 | $15.0M |
| 2026-06-17 | Bailey Gregory | A-Award | 3,333,333 | $16.7M |
| 2026-06-17 | Bailey Gregory | C-Conversion | 1,770,805 | $4.0M |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $259000 | $7.4M | $6.7M | $2.4M | $527000 | $584000 | $645000 | $7.6M | $3.7M | $3.1M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $308000 | $107000 | $131000 | $363000 | $326000 | $25000 | $4000 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $688000 | $7.6M | $7.9M | $4.1M | $2.3M | $2.2M | $2.5M | $7.6M | $5.7M | $6.1M |
| Immobilisations Corporelles | $195000 | $129000 | $90000 | $1.1M | 0 | 0 | 0 | $1.3M | $1.0M | $842000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | $2.2M | $1.6M | 0 | $738000 | 0 | 0 | 0 |
| Actifs Totaux | $3.2M | $9.6M | $10.7M | $7.4M | $3.9M | $3.2M | $3.2M | $9.0M | $6.7M | $7.0M |
| Dettes Fournisseurs | $261000 | $75000 | $150000 | $420000 | $761000 | $193000 | $568000 | $580000 | $744000 | $1.9M |
| Dette à Court Terme | 0 | 0 | 0 | $428000 | $2.4M | $7.1M | $7.6M | 0 | 0 | 0 |
| Passifs Courants | $25.6M | $1.3M | $2.4M | $3.3M | $5.4M | $9.0M | $10.1M | $1.4M | $2.4M | $3.6M |
| Dette à Long Terme | 0 | 0 | 0 | $1.5M | $3.9M | $6.1M | $10.5M | $3.0M | 0 | $196000 |
| Passifs Totaux | $25.6M | $1.3M | $2.4M | $4.8M | $9.3M | $15.0M | $20.6M | $41.3M | $6.2M | $7.0M |
| Réserves | -$60.0M | -$66.6M | -$74.1M | -$86.2M | -$97.1M | -$105.7M | -$116.2M | -$33.2M | -$44.3M | -$63.5M |
| Capitaux Propres | -$23.4M | $7.3M | $7.4M | $2.2M | -$5.1M | -$11.8M | -$17.2M | -$32.3M | $641000 | -$37000 |
| Dette Totale | 0 | 0 | 0 | $2.0M | $6.3M | $13.2M | $18.1M | $3.4M | $268000 | $196000 |
| Dette Nette | -$259000 | -$7.4M | -$6.7M | -$396000 | $5.8M | $12.6M | $17.5M | -$4.2M | -$3.4M | -$2.9M |
| Fonds de Roulement | -$24.9M | $6.3M | $5.4M | $757000 | -$3.1M | -$6.7M | -$7.6M | $6.2M | $3.3M | $2.5M |
Santé financière
| Dette / Capitaux propres | 0.17 |
| Ratio de liquidité | 6.65 |
Rentabilité
| Rentabilité des capitaux propres | -222.42% |
| Rentabilité du capital investi | -116.37% |
| Rentabilité des actifs | -82.03% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ALGS · BRNS · CVM · GNTA · GRCE · INMB · JUNS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SER: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions